Valley National Advisers Inc. Has $97,000 Stock Holdings in Cardinal Health, Inc. $CAH

Valley National Advisers Inc. decreased its holdings in shares of Cardinal Health, Inc. (NYSE:CAHFree Report) by 96.2% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 621 shares of the company’s stock after selling 15,709 shares during the quarter. Valley National Advisers Inc.’s holdings in Cardinal Health were worth $97,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Jones Financial Companies Lllp grew its stake in shares of Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after purchasing an additional 14,034 shares during the period. Atlantic Edge Private Wealth Management LLC boosted its holdings in Cardinal Health by 75.0% during the second quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after buying an additional 75 shares during the last quarter. Vermillion & White Wealth Management Group LLC grew its position in shares of Cardinal Health by 55.0% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock worth $34,000 after buying an additional 71 shares during the period. NewSquare Capital LLC grew its position in shares of Cardinal Health by 100.0% during the 2nd quarter. NewSquare Capital LLC now owns 214 shares of the company’s stock worth $36,000 after buying an additional 107 shares during the period. Finally, AlphaCore Capital LLC bought a new stake in shares of Cardinal Health in the 2nd quarter valued at about $41,000. 87.17% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

CAH has been the topic of several recent analyst reports. Wells Fargo & Company lifted their price objective on shares of Cardinal Health from $185.00 to $221.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 5th. Leerink Partners lifted their price target on shares of Cardinal Health from $211.00 to $230.00 and gave the stock an “outperform” rating in a research report on Monday, November 17th. Jefferies Financial Group set a $220.00 price target on shares of Cardinal Health and gave the company a “buy” rating in a report on Monday, November 3rd. Barclays began coverage on Cardinal Health in a research note on Monday, December 8th. They set an “overweight” rating and a $243.00 price objective on the stock. Finally, Argus boosted their target price on Cardinal Health from $189.00 to $211.00 and gave the company a “buy” rating in a research note on Tuesday, November 4th. Thirteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $209.00.

View Our Latest Research Report on CAH

Cardinal Health Stock Up 0.3%

Shares of NYSE:CAH opened at $208.19 on Monday. The firm has a market cap of $49.46 billion, a price-to-earnings ratio of 31.40, a PEG ratio of 1.52 and a beta of 0.63. Cardinal Health, Inc. has a 12 month low of $117.53 and a 12 month high of $214.93. The company’s fifty day simple moving average is $196.29 and its 200 day simple moving average is $170.26.

Cardinal Health (NYSE:CAHGet Free Report) last announced its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The firm had revenue of $64.01 billion during the quarter, compared to analyst estimates of $59.41 billion. During the same period in the prior year, the business earned $1.88 EPS. The company’s revenue for the quarter was up 22.4% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Research analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be issued a dividend of $0.5107 per share. The ex-dividend date is Friday, January 2nd. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio (DPR) is presently 30.77%.

Cardinal Health Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

See Also

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.